Philip Philip Md Explains How Physicians Should Test For Brca In Pancreatic Cancer Patients Obroncology Mp3 & Mp4 Download

2:02

philip philip md, phd, frcp, provides opinion on ngs and brca gene testing in pancreatic cancer

2:04

philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient

1:34

eileen o'reilly, md, describes how physicians should test for brca in pancreatic cancer patients

1:14

philip philip md, phd, frcp, on brca gene mutations & outcomes in pancreatic cancer

2:03

philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer

1:49

philip philip md, phd, frcp, on screening patients at high risk for pancreatic cancer

5:17

philip philip md, phd, frcp, discusses outcomes from the polo trial in pancreatic cancer

3:00

philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas

4:42

philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma

2:19

philip philip, md, on the outcomes of the polo study and its importance to physicians

1:17

dr. philip philip on choosing the right treatment for advanced pancreatic cancer patients

2:43

philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer

1:35

philip philip, md, on integrating immunotherapy into existing treatment regimens for crc patients

1:50

philip philip md, phd, frcp, considers molecular subtyping of pancreatic cancer

2:21

philip philip, md, on what we’ve learned about the duration of therapy in the adjuvant crc setting

3:30

comment: it is essential to identify the brca gene in pancreatic cancer patients allowing them t...

2:51

philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018

0:57

philip philip, md, provides thoughts on the role of parp inhibitors in advanced pancreatic cancer

2:17

philip philip, md, explains how physicians should test for brca in pancreatic cancer patients

Download video MP4

Download video MP3

Similar videos

philip philip md, phd, frcp, provides opinion on ngs and brca gene testing in pancreatic cancer

philip philip, md, shares opinion on treatment of a brca pancreatic cancer patient

eileen o'reilly, md, describes how physicians should test for brca in pancreatic cancer patients

philip philip md, phd, frcp, on brca gene mutations & outcomes in pancreatic cancer

philip philip md, phd, frcp, on neoadjuvant chemotherapy & upfront surgery in pancreatic cancer

philip philip md, phd, frcp, on screening patients at high risk for pancreatic cancer

philip philip md, phd, frcp, discusses outcomes from the polo trial in pancreatic cancer

philip philip, md, on the phase 2 study comparing chemo with or without veliparib in pancreas

philip philip md, phd, frcp, on the apact trial in surgically resected pancreatic adenocarcinoma

philip philip, md, on the outcomes of the polo study and its importance to physicians

dr. philip philip on choosing the right treatment for advanced pancreatic cancer patients

philip philip, md, phd, frcp, considers the impact of immunotherapy agents in pancreatic cancer

philip philip, md, on integrating immunotherapy into existing treatment regimens for crc patients

philip philip md, phd, frcp, considers molecular subtyping of pancreatic cancer

philip philip, md, on what we’ve learned about the duration of therapy in the adjuvant crc setting

comment: it is essential to identify the brca gene in pancreatic cancer patients allowing them t...

philip philip, md, phd, frcp, on the implications of the lapact study presented at asco 2018

philip philip, md, provides thoughts on the role of parp inhibitors in advanced pancreatic cancer

philip philip, md, reflects on the impact of pegph20 in met pancreatic cancer